FerroptoCure Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $3.1M

  • Investors
  • 18

FerroptoCure General Information

Description

Developer of therapeutic drugs designed to develop anticancer therapies based on scientific evidence. The company has created an anticancer drug that utilizes ferroptosis, next-generation sequencing, data informatics, and in silico analysis, enabling patients with cancer to get a proper cure and treatment.

Contact Information

Website
www.ferroptocure.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Duplex Fujimi B's 4th Floor
  • 1-3-11 Fujimi, Chiyoda-ku
  • Tokyo, 102-0071
  • Japan
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • Duplex Fujimi B's 4th Floor
  • 1-3-11 Fujimi, Chiyoda-ku
  • Tokyo, 102-0071
  • Japan

FerroptoCure Timeline

2023202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

FerroptoCure Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Early Stage VC (Series A) 22-Sep-2025 $3.1M Completed Clinical Trials - Phase 1
12. Accelerator/Incubator 03-Sep-2025 Completed Clinical Trials - Phase 1
11. Grant 30-May-2025 Completed Clinical Trials - Phase 1
10. Accelerator/Incubator Completed Clinical Trials - Phase 1
9. Accelerator/Incubator Completed Clinical Trials - Phase 1
8. Accelerator/Incubator 13-Sep-2023 Completed Clinical Trials - Phase 1
7. Accelerator/Incubator 14-Jul-2023 Completed Pre-Clinical Trials
6. Seed Round 24-Mar-2023 Completed Pre-Clinical Trials
5. Accelerator/Incubator 28-Feb-2023 Completed Pre-Clinical Trials
4. Accelerator/Incubator 01-Jan-2023 Completed Pre-Clinical Trials
To view FerroptoCure’s complete valuation and funding history, request access »

FerroptoCure Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
A preferred
To view FerroptoCure’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

FerroptoCure Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

FerroptoCure Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Tokyo University of Science Innovation Capital Corporation Minority
Vision Incubate Venture Capital Minority
MEDISO Accelerator/Incubator
Institute for the Global Entrepreneur Accelerator/Incubator
Japan External Trade Organization Accelerator/Incubator
You’re viewing 5 of 18 investors. Get the full list »

Ready to get started?

Request a free trial

FerroptoCure FAQs

  • When was FerroptoCure founded?

    FerroptoCure was founded in 2022.

  • Where is FerroptoCure headquartered?

    FerroptoCure is headquartered in Tokyo, Japan.

  • What is the size of FerroptoCure?

    FerroptoCure has 10 total employees.

  • What industry is FerroptoCure in?

    FerroptoCure’s primary industry is Drug Discovery.

  • Is FerroptoCure a private or public company?

    FerroptoCure is a Private company.

  • What is FerroptoCure’s current revenue?

    The current revenue for FerroptoCure is .

  • How much funding has FerroptoCure raised over time?

    FerroptoCure has raised $7.33M.

  • Who are FerroptoCure’s investors?

    Tokyo University of Science Innovation Capital, Vision Incubate, MEDISO, Institute for the Global Entrepreneur, and Japan External Trade Organization are 5 of 18 investors who have invested in FerroptoCure.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process